Approval · Notice of Compliance 1869 · 1999
DOM-INDAPAMIDE: Notice of Compliance 1869
Issued April 6, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1869
- Date
- April 6, 1999
- Company
- Dominion PharmacalMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Therapeutic class
- Diuretic/antihypertensive agent
- Canadian reference product
- LOZIDE (Servier Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOM-INDAPAMIDE | 02239913 | Cancelled Post Market |
| DOM-INDAPAMIDE | 02239917 | Cancelled Post Market |
Medicinal ingredients
- INDAPAMIDE HEMIHYDRATE 1.25 MG per TAB
- INDAPAMIDE HEMIHYDRATE 2.5 MG per TAB